Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results

Clinical and Translational Oncology

Volumn 11, Issue 5, 2009, Pages 276-283

  Cárdenes, Higinia R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Hepatocellular cancer; SBRT; Stereotactic body radiotherapy

Indexed keywords

FLOXURIDINE; IODINATED POPPYSEED OIL;

CANCER GRADING; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CLINICAL TRIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAXIMUM TOLERATED DOSE; PATIENT POSITIONING; RADIATION DOSE; RADIATION INDUCED LIVER DISEASE; RADIATION INJURY; RADIOFREQUENCY ABLATION; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; TARGET ORGAN; LIVER TUMOR; METHODOLOGY; RADIOSURGERY;

CARCINOMA, HEPATOCELLULAR; CLINICAL TRIALS AS TOPIC; HUMANS; LIVER NEOPLASMS; RADIOSURGERY;

EID: 68849125246     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-009-0355-5     Document Type: Review

References (52)

1. D.M. Parkin F. Bray J. Ferlay P. Pisani 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 11668491 10.1002/ijc.1440 1:CAS:528:DC%2BD3MXntVGlu78%3D (Pubitemid 32911406)
2. H.B. El-Serag A.C. Mason 1999 Rising incidence of hepatocellular carcinoma in the United States [see comment] N Engl J Med 340 745 750 10072408 10.1056/NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D (Pubitemid 29114292)
3. J. Bruix M. Sherman 2005 Practice guidelines committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. AASLD Practice Guideline Hepatology 42 1208 1236 16250051 10.1002/hep.20933 (Pubitemid 43112690)
4. American Joint Committee on Cancer (2002) Cancer staging handbook. Springer Verlag, New York
5. K. Okuda T. Ohtsuki H. Obata, et al. 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928 2990661 10.1002/1097-0142(19850815)56:4<918::AID- CNCR2820560437>3.0.CO;2-E 1:STN:280:DyaL2M3lsVaqtw%3D%3D (Pubitemid 15228292)
6. R.N. Pugh I.M. Murray-Lyon J.L. Dawson, et al. 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 4541913 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D
7. E. Christensen 2004 Prognostic models including the Child-Pugh, MELD and Mayo risk scores - where are we and where should we go? J Hepatol 41 344 350 15288486 10.1016/j.jhep.2004.06.005 (Pubitemid 39177643)
8. P.S. Kamath R.H. Wiesner M. Malinchoc, et al. 2001 A model to predict survival in patients with end-stage liver disease [see comment] Hepatology 33 464 470 11172350 10.1053/jhep.2001.22172 1:STN:280:DC%2BD3M7kvVOqug%3D%3D (Pubitemid 32119037)
9. J. Bruix L. Boix M. Sala J.M. Llovet 2004 Focus on hepatocellular carcinoma Cancer Cell 5 215 219 15050913 10.1016/S1535-6108(04)00058-3 1:CAS:528:DC%2BD2cXjtVartbs%3D (Pubitemid 38402113)
10. (1998) A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (clip) investigators [see comment]. Hepatology 28:751-755
11. J.M. Llovet C. Bru J. Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329 338 10518312 10.1055/s-2007-1007122 1:STN:280:DyaK1Mvks1Grsg%3D%3D
12. V. Mazzaferro E. Regalia R. Doci, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [see comment] N Engl J Med 334 693 699 8594428 10.1056/NEJM199603143341104 1:STN:280:DyaK287nsFWltw%3D%3D (Pubitemid 26079803)
13. J.M. Llovet J. Fuster J. Bruix 1999 Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation [see comment] Hepatology 30 1434 1440 10573522 10.1002/hep.510300629 1:STN:280:DC%2BD3c%2Fkt1eiug%3D%3D
14. S. Arii Y. Yamaoka S. Futagawa, et al. 2000 Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 32 1224 1229 11093728 10.1053/jhep.2000.20456 1:STN:280: DC%2BD3M%2FntFegsQ%3D%3D
15. R. Vilana J. Bruix C. Bru, et al. 1992 Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma Hepatology 16 353 357 1322349 10.1002/hep.1840160212 1:STN:280:DyaK38zkslyjsw%3D%3D
16. L.-X. Liu H.-C. Jiang D.-X. Piao 2002 Radiofrequence ablation of liver cancers World J Gastroenterol 8 393 399 12046057
17. J.M. Llovet J. Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 12540794 10.1053/jhep.2003.50047 1:CAS:528: DC%2BD3sXhsFeltrg%3D (Pubitemid 36152543)
18. R. Salem R.D. Hunter 2006 Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review Int J Radiat Oncol Biol Phys 66 S83 88 16979447 1:CAS:528:DC%2BD28Xps1Wlsb8%3D
19. Llovet J, Ricci S, Mazzaferro V, SHARP Investigators Study Group (2007) Sorafenib improves survival in hepatocellular carcinoma: results of a phase III randomized placebo-controlled trial. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I. 25:LBA1
20. J.M. Llovet S. Ricci V. Mazzaferro, et al. 2008 Sorafenib in advanced hepatocellular carcinoma [see comment] N Engl J Med 359 378 390 18650514 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D
21. R.A. Abrams T.F. Pajak T.L. Haulk, et al. 1998 Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center Cancer J Sci Am 4 178 184 9612600 1:STN:280:DyaK1c3nsFGntQ%3D%3D
22. G.B. Stillwagon S.E. Order C. Guse, et al. 1989 194 Hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a radiation therapy oncology group study Int J Radiat Oncol Biol Phys 17 1223 1229 2557307 1:STN:280:DyaK3c%2Fptl2jtw%3D%3D
23. J.M. Robertson T.S. Lawrence L.M. Dworzanin, et al. 1993 Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy J Clin Oncol 11 1286 1293 8391066 1:STN:280:DyaK3szgtFKlsA%3D%3D
24. L.A. Dawson C.J. McGinn D. Normolle, et al. 2000 Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies J Clin Oncol 18 2210 2218 10829040 1:CAS:528:DC%2BD3cXktlagsb4%3D
25. M.-T. Liu S.-H. Li T.-C. Chu, et al. 2004 Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization Jpn J Clin Oncol 34 532 539 15466827 10.1093/jjco/hyh089 (Pubitemid 43118049)
26. J. Seong H.C. Park K.H. Han C.Y. Chon 2003 Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients Int J Radiat Oncol Biol Phys 55 329 336 12527045
27. F. Mornex N. Girard C. Beziat, et al. 2006 Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma noneligible for curative therapies - mature results of the French phase Phase II RTF-1 Trial Int J Radiat Oncol Biol Phys 66 1152 1158 17145534
28. H.C. Park J. Seong K.H. Han, et al. 2002 Dose-response relationship in local radiotherapy for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 54 150 155 12182985 10.1016/S0360-3016(02)03283-2
29. D.Y. Kim W. Park D.H. Lim, et al. 2005 Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma Cancer 103 2419 2426 15822130 10.1002/cncr.21043 (Pubitemid 40686589)
30. L.A. Dawson D. Normolle J.M. Balter, et al. 2002 Analysis of radiation-induced liver disease using the Lyman NTCP model [see comment] Int J Radiat Oncol Biol Phys 53 810 821 12095546
31. T.S. Lawrence R.K. Ten Haken M.L. Kessler, et al. 1992 The use of 3-D dose volume analysis to predict radiation hepatitis Int J Radiat Oncol Biol Phys 23 781 788 1618671 1:STN:280:DyaK38zhs1yjtg%3D%3D
32. A.H. Russell C. Clyde T.H. Wasserman, et al. 1993 Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol Int J Radiat Oncol Biol Phys 27 117 123 8365932 1:STN:280:DyaK3sznsVKgtA%3D%3D
33. J.T. Lyman 1985 Complication probability as assessed from dose-volume histograms Radiat Res Suppl 8 S13 19 3867079 10.2307/3583506 1:STN:280:DyaL287itFKjtg%3D%3D
34. J.-H. Cheng J.K. Wu C.M. Huang, et al. 2002 Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description Radiother Oncol 63 41 45 12065102 10.1016/S0167-8140(02)00061-0 (Pubitemid 34626753)
35. J.-H. Cheng J.-K. Wu P.-T. Lee, et al. 2004 Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease Int J Radiat Oncol Biol Phys 60 1502 1509 15590181 10.1016/j.ijrobp.2004.06.069
36. Z.-Y. Xu S.-X. Liang J. Zhu, et al. 2006 Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma [see comment] Int J Radiat Oncol Biol Phys 65 189 195 16542787
37. H. Blomgren I. Lax H. Goranson, et al. 1998 Radiosurgery for tumors of in the body: clinical experience using a new method J Radiosurg 1 63 74 10.1023/B:JORA.0000010880.40483.c4
38. H. Blomgren I. Lax I. Naslund R. Svanstrom 1995 Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients Acta Oncol 34 861 870 7576756 10.3109/02841869509127197 1:STN:280:DyaK28%2FjvVOqtQ%3D%3D
39. I. Lax H. Blomgren I. Naslund R. Svanstrom 1994 Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects Acta Oncol 33 677 683 7946448 10.3109/02841869409121782 1:STN:280:DyaK2M%2Fjtlegug%3D%3D
40. C.R. Kelsey R. Shchefter P. Nash, et al. 2003 Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for extracranial stereotactic radiosurgery Int J Radiat Oncol Biol Phys 57 S283
41. Cao M, Cardenes H, Langer M et al (2008) Evaluation of automatic volume match function for kilovoltage cone-beam CT (CBCT) guided patient setup. American Association of Physicists in Medicine, Houston, TX
42. L.A. Dawson C. Eccles J.-P. Bissonnette K.K. Brock 2005 Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control Int J Radiat Oncol Biol Phys 62 1247 1252 15990028
43. K.K. Herfarth J. Debus F. Lohr, et al. 2001 Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial J Clin Oncol 19 164 170 11134209 1:STN:280:DC%2BD38%2Fgs1Sgsg%3D%3D
44. J. Wulf M. Guckenberger U. Haedinger, et al. 2006 Stereotactic radiotherapy of primary liver cancer and hepatic metastases Acta Oncol 45 838 847 16982548 10.1080/02841860600904821 (Pubitemid 44423130)
45. B.O. Choi H.S. Jang K.M. Kang, et al. 2006 Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma Jpn J Clin Oncol 36 154 158 16520355 10.1093/jjco/hyi236
46. A. Méndez Romero W. Wunderink S.M. Hussain, et al. 2006 Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study Acta Oncol 45 831 837 16982547 10.1080/02841860600897934 (Pubitemid 44423129)
47. R.V. Tse M. Hawkins G. Lockwood, et al. 2008 Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 657 664 18172187 10.1200/JCO.2007.14.3529 (Pubitemid 351264363)
48. H. Cardenes T. Price S. Perkins, et al. 2008 Phase I trial of stereotactic body radiation therapy for primary hepatocellular carcinoma Int J Radiat Oncol Biol Phys 72 S128 S129
49. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003 ( http://ctep.cancer.gov ), Publish Date: August 9, 2006
50. P. Therasse S.G. Arbuck E.A. Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [see comment] J Natl Cancer Inst 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
51. B.G. Douglas J.F. Fowler 1976 The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation Radiat Res 66 401 426 1265229 10.2307/3574407 1:STN:280:DyaE287nslWntg%3D%3D
52. C. Park L. Papiez S. Zhang, et al. 2008 Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy [see comment] Int J Radiat Oncol Biol Phys 70 847 852 18262098